fermedics

What fermedics does

Fermedics bv is a Belgian privately held B2B ingredient supplier founded in 2019 and headquartered in Ghent, Belgium. The company develops fermented botanical ingredients and prebiotic-postbiotic blends for nutraceutical brands, food supplement manufacturers, and functional food producers, primarily across European markets including Benelux, Germany, France, the UK, and Spain. Its customers include named nutraceutical brands such as Bonusan, Sunday Natural, SuperSmart, Supplemed, Terranova, and Bioksan.

The company's core technology is the proprietary PhytoFerm™ platform, a targeted and controlled fermentation process that transforms plant extracts into bioavailable, metabolically active forms through three mechanisms: plant matrix breakdown, enzymatic bioconversion into bioactive metabolites, and generation of beneficial postbiotic compounds. Under this platform, Fermedics markets 18+ branded ingredients spanning cardiovascular (FBG22® fermented black garlic, Ankascin® 568-P monacolin-free red yeast rice, Fermokinase® nattokinase, Fermakinon-7® vitamin K2), cognitive and adaptogenic (Fermogulan®, Fermodiola®, Fermanolide®, Thearelax®, Ferzinger®), metabolic and longevity (Fermeric®, Fermidine®, Fermogranate™, FRG12™), gut health and prebiotic-postbiotic (Fibriotics®, Berriotics®, Fermbucha®), and functional mushroom (ProAntro®) categories. Each product pairs a substrate-specific fermentation protocol with quantified bioactive yields and clinical or peer-reviewed substantiation.

Fermedics operates an enterprise B2B sales motion, selling standardized ingredient powders to formulators through direct engagement, with quote-based pricing tied to volume and standardization. Revenue is generated through bulk ingredient orders; no consumer-facing or retail channels. Key partnerships include SunWay Biotech (Taiwan) for European distribution of Ankascin® 568-P and BotaniCERT (France) for independent third-party quality verification under the Botani+ certification scheme. The company is actively positioning for regulatory tailwinds, particularly the EU ban on monacolins from red yeast rice expected in Q3 2026.

Name

fermedics

Legal name

Fermedics bv

Website

https://fermedics.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Fercedics is a Belgian B2B supplier of fermented botanical ingredients and prebiotic-postbiotic blends, using its proprietary PhytoFerm™ fermentation technology to serve nutraceutical brands and functional food manufacturers across European markets with 18+ branded standardized ingredients.

Ownership category

akta.pro rank

Product category

Fermented Botanical Ingredients

NAICS

Food Manufacturing (311)

SIC

Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts) (CRADAOAI)

akta.pro secondary industries

Fermented Tea & Botanical Beverage Production (Jun, Kvass, etc.) (AFAFAHAD), Pickled & Fermented Foods Manufacturing (AFAKACAI)

Keywords

• Fermented botanical ingredients
• Nutraceutical ingredient supply
• Prebiotic postbiotic blends
• Targeted fermentation technology
• Bioactive botanical extracts

Headquarters

HQ city

Ghent

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

1. B2B Fermented Botanical Ingredients Sales: Direct B2B sales of fermented botanical ingredient powders to nutraceutical brands, food supplement manufacturers, and functional food companies. Ingredients are sold as standardized powders for use in capsules, tablets, sachets, and other delivery formats. Revenue is generated through bulk ingredient orders with pricing based on volume and standardization levels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Fermedics develops and sells a portfolio of branded fermented botanical ingredients and prebiotic-postbiotic blends using its proprietary PhytoFerm™ targeted fermentation technology. The company supplies standardized fermented ingredient powders (e.g., FBG22® fermented black garlic, Ankascin® 568-P monacolin-free red yeast rice, Fermogulan®, Fermeric®, Fermakinon-7®) to nutraceutical brands and functional food manufacturers for use in capsules, tablets, sachets, and functional food applications.

Product overview

Fermedics is a global leader in fermented botanical ingredients, offering a portfolio of 18+ branded ingredient products powered by its proprietary PhytoFerm™ fermentation technology. The portfolio includes single-ingredient fermented botanicals (FBG22®, Ankascin® 568-P, Fermogulan®, Fermodiola®, Fermeric®, Fermanolide®, Ferzinger®, FRG12™, Fermogranate™), specialised nutrient ingredients (Fermakinon-7®, Fermidine®, Fermokinase®), functional mushroom products (ProAntro®), L-theanine ingredient (Thearelax®), and prebiotic-postbiotic blends (Fibriotics®, Berriotics®, Fermbucha®). All products undergo targeted fermentation to enhance bioavailability, generate bioactive metabolites, and create postbiotic compounds for superior health solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• FBG22® Triple fermented black garlic extract standardised to ≥1% S-Allyl-Cysteine (SAC), the highest standardisation level commercially available, delivering cardiovascular health benefits including blood pressure reduction, cholesterol management, and antioxidant protection. For nutraceutical brand formulators.
• Ankascin® 568-P Monacolin-free fermented red yeast rice ingredient produced using Monascus purpureus NTU568, standardised to ≥0.7% Monascin and ≥0.23% Ankaflavin, providing cardiovascular benefits including cholesterol, blood lipid, blood sugar, and blood pressure control. For cardiovascular supplement brands seeking regulatory-stable formulation.
• Fermogulan®
• Fermodiola®
• Thearelax®
• ProAntro®
• Fermokinase®
• Fermidine®
• Fermakinon-7®
• Fermanolide®
• Ferzinger®
• Fibriotics®
• Berriotics®
• Fermbucha®
• Fermogranate™
• FRG12™
• Fermeric®

Quantifiable outcome

• 17× improved bioavailability of curcuminoids (Fermeric®)
• +9 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature17 records

Partnerships

Two partnerships are on record, tiered core and supporting.

• SunWay Biotech (Taiwan)coreStrategic or Co-development PartnerSunWay Biotech developed Ankascin® 568-P fermented red yeast rice using proprietary Monascus purpureus NTU568 strain patented by SunWay Biotech. Fermedics distributes Ankascin® 568-P in Europe. The partnership combines SunWay's fermentation expertise and proprietary strain with Fermedics' European market access and distribution network. Five proprietary randomized double-blind placebo-controlled clinical trials were conducted by SunWay Biotech in collaboration with Taiwanese universities.
• BotaniCERTsupportingTechnology or IntegrationBotaniCERT is an independent French certification body specializing in botanical ingredient authentication. Provides the Botani+ quality label for FBG22® fermented black garlic extract. Applies non-targeted UHPLC-DAD and UHPLC-MS/MS to screen full phytochemical profile of every batch, verifying species identity (Allium sativum L.), absence of undeclared plant material, absence of artificial enrichment including chemical SAC addition, and quantitative SAC content by UHPLC-UV.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BioGaia: Swedish probiotic strain and finished-brand company selling Lactobacillus reuteri-based ingredients and products with strong clinical evidence into supplement, infant nutrition, and OTC channels. Comparable to Fermedics as a science-backed, branded ingredient/B2B supplier with fermentation-derived active ingredients.
• AB Biotics: Spanish probiotic and botanical ingredient company selling branded probiotic strains and nutraceutical actives to supplement manufacturers across Europe. Closely comparable in size, geography, and B2B-branded ingredient model, though more probiotic-focused than Fermedics' botanical fermentation angle.
• PLT Health Solutions: North American branded ingredient platform supplying science-backed botanical, mushroom, and postbiotic ingredients (e.g., Zynamite®, Muniq®, Earthlight®) to dietary supplement and functional food brands. Closely mirrors Fermedics' model of branded, clinically supported ingredients sold B2B to nutraceutical formulators.
• Sabinsa: US- and India-based branded nutraceutical ingredient manufacturer selling standardized botanical extracts (e.g., Curcumin C3 Complex, BioPerine, Lactospore) to global supplement brands with strong clinical research dossiers. Directly comparable to Fermedics as a science-led, branded-ingredient B2B supplier targeting nutraceutical formulators.
• Lallemand Health Solutions: Canadian/French supplier of probiotic, yeast-based, and fermentation-derived ingredients for the human nutrition and supplement markets. Comparable to Fermedics in its reliance on proprietary fermentation platforms and B2B sales to nutraceutical brands across Europe and globally.
• Gnosis by Lesaffre: Business unit of Lesaffre specializing in fermentation-derived nutraceutical ingredients (Quatrefolic®, LifeinU® B. subtilis, Lynside® yeast-based nutrients) sold B2B to supplement and functional food manufacturers. Highly comparable as a fermentation-led, branded nutraceutical ingredient supplier.

Broad incumbents

• Novonesis: Danish bioscience major formed by the Novozymes–Chr. Hansen merger, with a strong Human Health platform supplying probiotic, enzyme, and fermentation-derived ingredients to dietary supplement and food manufacturers. Comparable to Fermedics in leveraging fermentation know-how for branded nutraceutical ingredients, but at vastly greater scale.
• DSM-Firmenich: Dutch/Swiss nutrition, health, and beauty ingredients major with a fermentation-derived ingredient portfolio (vitamins, HMOs, postbiotics via the post-Biothera acquisition) sold globally to supplement and functional-food manufacturers. Competes with Fermedics at the ingredient level across multiple categories while serving a much broader customer base.
• Kerry Group: Irish-listed taste and nutrition group operating a ProHealth ingredient portfolio including branded probiotics, postbiotics, and botanicals sold to nutraceutical and functional-food brands in Europe and globally. Comparable as a B2B fermentation/biotics ingredient supplier with overlapping end customers, though embedded in a much larger taste-and-nutrition business.
• ADM Nutrition: Global ingredient powerhouse with a Nutrition segment that includes plant-based bioactives, probiotics, and fermentation-derived ingredients (via Biopolis and others). Comparable as a competing supplier of fermented bioactives to the same nutraceutical and functional-food brand customers, but operating at much larger scale with a broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fermedics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about fermedics